Global Crohn’s Disease Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Crohn’s Disease Therapeutics market size was valued at US$ 3248.1 million in 2023. With growing demand in downstream market, the Crohn’s Disease Therapeutics is forecast to a readjusted size of US$ 3593 million by 2030 with a CAGR of 1.5% during review period.
The research report highlights the growth potential of the global Crohn’s Disease Therapeutics market. Crohn’s Disease Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Crohn’s Disease Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Crohn’s Disease Therapeutics market.
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Crohn’s Disease Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Crohn’s Disease Therapeutics market. It may include historical data, market segmentation by Type (e.g., Non-Surgical, Surgical), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Crohn’s Disease Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Crohn’s Disease Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Crohn’s Disease Therapeutics industry. This include advancements in Crohn’s Disease Therapeutics technology, Crohn’s Disease Therapeutics new entrants, Crohn’s Disease Therapeutics new investment, and other innovations that are shaping the future of Crohn’s Disease Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Crohn’s Disease Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Crohn’s Disease Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Crohn’s Disease Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Crohn’s Disease Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Crohn’s Disease Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Crohn’s Disease Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Crohn’s Disease Therapeutics market.
Market Segmentation:
Crohn’s Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Crohn’s Disease Therapeutics market size was valued at US$ 3248.1 million in 2023. With growing demand in downstream market, the Crohn’s Disease Therapeutics is forecast to a readjusted size of US$ 3593 million by 2030 with a CAGR of 1.5% during review period.
The research report highlights the growth potential of the global Crohn’s Disease Therapeutics market. Crohn’s Disease Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Crohn’s Disease Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Crohn’s Disease Therapeutics market.
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Crohn’s Disease Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Crohn’s Disease Therapeutics market. It may include historical data, market segmentation by Type (e.g., Non-Surgical, Surgical), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Crohn’s Disease Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Crohn’s Disease Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Crohn’s Disease Therapeutics industry. This include advancements in Crohn’s Disease Therapeutics technology, Crohn’s Disease Therapeutics new entrants, Crohn’s Disease Therapeutics new investment, and other innovations that are shaping the future of Crohn’s Disease Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Crohn’s Disease Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Crohn’s Disease Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Crohn’s Disease Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Crohn’s Disease Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Crohn’s Disease Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Crohn’s Disease Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Crohn’s Disease Therapeutics market.
Market Segmentation:
Crohn’s Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Non-Surgical
- Surgical
- Hospitals
- Ambulatory Surgical Centers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson and Johnson Services Inc.
- Pfizer Inc.
- Allergan
- AbbVie Inc.
- Takeda Pharmaceutical Company Limited
- Celgene Corporation
- Perrigo Company PLC
- Ferring B.V.
- Salix Pharmaceuticals
- Gilead Sciences Inc.
- Genentech Inc.
- UCB India Private Limited.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Crohn’s Disease Therapeutics Market Size 2019-2030
2.1.2 Crohn’s Disease Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Crohn’s Disease Therapeutics Segment by Type
2.2.1 Non-Surgical
2.2.2 Surgical
2.3 Crohn’s Disease Therapeutics Market Size by Type
2.3.1 Crohn’s Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Crohn’s Disease Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.5 Crohn’s Disease Therapeutics Market Size by Application
2.5.1 Crohn’s Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
3 CROHN’S DISEASE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Crohn’s Disease Therapeutics Market Size Market Share by Players
3.1.1 Global Crohn’s Disease Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Crohn’s Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CROHN’S DISEASE THERAPEUTICS BY REGIONS
4.1 Crohn’s Disease Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Crohn’s Disease Therapeutics Market Size Growth (2019-2024)
4.3 APAC Crohn’s Disease Therapeutics Market Size Growth (2019-2024)
4.4 Europe Crohn’s Disease Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Crohn’s Disease Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Crohn’s Disease Therapeutics Market Size by Country (2019-2024)
5.2 Americas Crohn’s Disease Therapeutics Market Size by Type (2019-2024)
5.3 Americas Crohn’s Disease Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Crohn’s Disease Therapeutics Market Size by Region (2019-2024)
6.2 APAC Crohn’s Disease Therapeutics Market Size by Type (2019-2024)
6.3 APAC Crohn’s Disease Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Crohn’s Disease Therapeutics by Country (2019-2024)
7.2 Europe Crohn’s Disease Therapeutics Market Size by Type (2019-2024)
7.3 Europe Crohn’s Disease Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Crohn’s Disease Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CROHN’S DISEASE THERAPEUTICS MARKET FORECAST
10.1 Global Crohn’s Disease Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Crohn’s Disease Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Crohn’s Disease Therapeutics Forecast
10.1.3 APAC Crohn’s Disease Therapeutics Forecast
10.1.4 Europe Crohn’s Disease Therapeutics Forecast
10.1.5 Middle East & Africa Crohn’s Disease Therapeutics Forecast
10.2 Americas Crohn’s Disease Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Crohn’s Disease Therapeutics Market Forecast
10.2.2 Canada Crohn’s Disease Therapeutics Market Forecast
10.2.3 Mexico Crohn’s Disease Therapeutics Market Forecast
10.2.4 Brazil Crohn’s Disease Therapeutics Market Forecast
10.3 APAC Crohn’s Disease Therapeutics Forecast by Region (2025-2030)
10.3.1 China Crohn’s Disease Therapeutics Market Forecast
10.3.2 Japan Crohn’s Disease Therapeutics Market Forecast
10.3.3 Korea Crohn’s Disease Therapeutics Market Forecast
10.3.4 Southeast Asia Crohn’s Disease Therapeutics Market Forecast
10.3.5 India Crohn’s Disease Therapeutics Market Forecast
10.3.6 Australia Crohn’s Disease Therapeutics Market Forecast
10.4 Europe Crohn’s Disease Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Crohn’s Disease Therapeutics Market Forecast
10.4.2 France Crohn’s Disease Therapeutics Market Forecast
10.4.3 UK Crohn’s Disease Therapeutics Market Forecast
10.4.4 Italy Crohn’s Disease Therapeutics Market Forecast
10.4.5 Russia Crohn’s Disease Therapeutics Market Forecast
10.5 Middle East & Africa Crohn’s Disease Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Crohn’s Disease Therapeutics Market Forecast
10.5.2 South Africa Crohn’s Disease Therapeutics Market Forecast
10.5.3 Israel Crohn’s Disease Therapeutics Market Forecast
10.5.4 Turkey Crohn’s Disease Therapeutics Market Forecast
10.5.5 GCC Countries Crohn’s Disease Therapeutics Market Forecast
10.6 Global Crohn’s Disease Therapeutics Forecast by Type (2025-2030)
10.7 Global Crohn’s Disease Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Johnson and Johnson Services Inc.
11.1.1 Johnson and Johnson Services Inc. Company Information
11.1.2 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Offered
11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Johnson and Johnson Services Inc. Main Business Overview
11.1.5 Johnson and Johnson Services Inc. Latest Developments
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Information
11.2.2 Pfizer Inc. Crohn’s Disease Therapeutics Product Offered
11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Inc. Main Business Overview
11.2.5 Pfizer Inc. Latest Developments
11.3 Allergan
11.3.1 Allergan Company Information
11.3.2 Allergan Crohn’s Disease Therapeutics Product Offered
11.3.3 Allergan Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Allergan Main Business Overview
11.3.5 Allergan Latest Developments
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Information
11.4.2 AbbVie Inc. Crohn’s Disease Therapeutics Product Offered
11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AbbVie Inc. Main Business Overview
11.4.5 AbbVie Inc. Latest Developments
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Information
11.5.2 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Offered
11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.5.5 Takeda Pharmaceutical Company Limited Latest Developments
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Information
11.6.2 Celgene Corporation Crohn’s Disease Therapeutics Product Offered
11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Celgene Corporation Main Business Overview
11.6.5 Celgene Corporation Latest Developments
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Information
11.7.2 Perrigo Company PLC Crohn’s Disease Therapeutics Product Offered
11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Perrigo Company PLC Main Business Overview
11.7.5 Perrigo Company PLC Latest Developments
11.8 Ferring B.V.
11.8.1 Ferring B.V. Company Information
11.8.2 Ferring B.V. Crohn’s Disease Therapeutics Product Offered
11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Ferring B.V. Main Business Overview
11.8.5 Ferring B.V. Latest Developments
11.9 Salix Pharmaceuticals
11.9.1 Salix Pharmaceuticals Company Information
11.9.2 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Offered
11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Salix Pharmaceuticals Main Business Overview
11.9.5 Salix Pharmaceuticals Latest Developments
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Information
11.10.2 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Offered
11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Gilead Sciences Inc. Main Business Overview
11.10.5 Gilead Sciences Inc. Latest Developments
11.11 Genentech Inc.
11.11.1 Genentech Inc. Company Information
11.11.2 Genentech Inc. Crohn’s Disease Therapeutics Product Offered
11.11.3 Genentech Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Genentech Inc. Main Business Overview
11.11.5 Genentech Inc. Latest Developments
11.12 UCB India Private Limited.
11.12.1 UCB India Private Limited. Company Information
11.12.2 UCB India Private Limited. Crohn’s Disease Therapeutics Product Offered
11.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 UCB India Private Limited. Main Business Overview
11.12.5 UCB India Private Limited. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Crohn’s Disease Therapeutics Market Size 2019-2030
2.1.2 Crohn’s Disease Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Crohn’s Disease Therapeutics Segment by Type
2.2.1 Non-Surgical
2.2.2 Surgical
2.3 Crohn’s Disease Therapeutics Market Size by Type
2.3.1 Crohn’s Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Crohn’s Disease Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.5 Crohn’s Disease Therapeutics Market Size by Application
2.5.1 Crohn’s Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
3 CROHN’S DISEASE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Crohn’s Disease Therapeutics Market Size Market Share by Players
3.1.1 Global Crohn’s Disease Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Crohn’s Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CROHN’S DISEASE THERAPEUTICS BY REGIONS
4.1 Crohn’s Disease Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Crohn’s Disease Therapeutics Market Size Growth (2019-2024)
4.3 APAC Crohn’s Disease Therapeutics Market Size Growth (2019-2024)
4.4 Europe Crohn’s Disease Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Crohn’s Disease Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Crohn’s Disease Therapeutics Market Size by Country (2019-2024)
5.2 Americas Crohn’s Disease Therapeutics Market Size by Type (2019-2024)
5.3 Americas Crohn’s Disease Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Crohn’s Disease Therapeutics Market Size by Region (2019-2024)
6.2 APAC Crohn’s Disease Therapeutics Market Size by Type (2019-2024)
6.3 APAC Crohn’s Disease Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Crohn’s Disease Therapeutics by Country (2019-2024)
7.2 Europe Crohn’s Disease Therapeutics Market Size by Type (2019-2024)
7.3 Europe Crohn’s Disease Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Crohn’s Disease Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CROHN’S DISEASE THERAPEUTICS MARKET FORECAST
10.1 Global Crohn’s Disease Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Crohn’s Disease Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Crohn’s Disease Therapeutics Forecast
10.1.3 APAC Crohn’s Disease Therapeutics Forecast
10.1.4 Europe Crohn’s Disease Therapeutics Forecast
10.1.5 Middle East & Africa Crohn’s Disease Therapeutics Forecast
10.2 Americas Crohn’s Disease Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Crohn’s Disease Therapeutics Market Forecast
10.2.2 Canada Crohn’s Disease Therapeutics Market Forecast
10.2.3 Mexico Crohn’s Disease Therapeutics Market Forecast
10.2.4 Brazil Crohn’s Disease Therapeutics Market Forecast
10.3 APAC Crohn’s Disease Therapeutics Forecast by Region (2025-2030)
10.3.1 China Crohn’s Disease Therapeutics Market Forecast
10.3.2 Japan Crohn’s Disease Therapeutics Market Forecast
10.3.3 Korea Crohn’s Disease Therapeutics Market Forecast
10.3.4 Southeast Asia Crohn’s Disease Therapeutics Market Forecast
10.3.5 India Crohn’s Disease Therapeutics Market Forecast
10.3.6 Australia Crohn’s Disease Therapeutics Market Forecast
10.4 Europe Crohn’s Disease Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Crohn’s Disease Therapeutics Market Forecast
10.4.2 France Crohn’s Disease Therapeutics Market Forecast
10.4.3 UK Crohn’s Disease Therapeutics Market Forecast
10.4.4 Italy Crohn’s Disease Therapeutics Market Forecast
10.4.5 Russia Crohn’s Disease Therapeutics Market Forecast
10.5 Middle East & Africa Crohn’s Disease Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Crohn’s Disease Therapeutics Market Forecast
10.5.2 South Africa Crohn’s Disease Therapeutics Market Forecast
10.5.3 Israel Crohn’s Disease Therapeutics Market Forecast
10.5.4 Turkey Crohn’s Disease Therapeutics Market Forecast
10.5.5 GCC Countries Crohn’s Disease Therapeutics Market Forecast
10.6 Global Crohn’s Disease Therapeutics Forecast by Type (2025-2030)
10.7 Global Crohn’s Disease Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Johnson and Johnson Services Inc.
11.1.1 Johnson and Johnson Services Inc. Company Information
11.1.2 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Offered
11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Johnson and Johnson Services Inc. Main Business Overview
11.1.5 Johnson and Johnson Services Inc. Latest Developments
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Information
11.2.2 Pfizer Inc. Crohn’s Disease Therapeutics Product Offered
11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Inc. Main Business Overview
11.2.5 Pfizer Inc. Latest Developments
11.3 Allergan
11.3.1 Allergan Company Information
11.3.2 Allergan Crohn’s Disease Therapeutics Product Offered
11.3.3 Allergan Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Allergan Main Business Overview
11.3.5 Allergan Latest Developments
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Information
11.4.2 AbbVie Inc. Crohn’s Disease Therapeutics Product Offered
11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AbbVie Inc. Main Business Overview
11.4.5 AbbVie Inc. Latest Developments
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Information
11.5.2 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Offered
11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.5.5 Takeda Pharmaceutical Company Limited Latest Developments
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Information
11.6.2 Celgene Corporation Crohn’s Disease Therapeutics Product Offered
11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Celgene Corporation Main Business Overview
11.6.5 Celgene Corporation Latest Developments
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Information
11.7.2 Perrigo Company PLC Crohn’s Disease Therapeutics Product Offered
11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Perrigo Company PLC Main Business Overview
11.7.5 Perrigo Company PLC Latest Developments
11.8 Ferring B.V.
11.8.1 Ferring B.V. Company Information
11.8.2 Ferring B.V. Crohn’s Disease Therapeutics Product Offered
11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Ferring B.V. Main Business Overview
11.8.5 Ferring B.V. Latest Developments
11.9 Salix Pharmaceuticals
11.9.1 Salix Pharmaceuticals Company Information
11.9.2 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Offered
11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Salix Pharmaceuticals Main Business Overview
11.9.5 Salix Pharmaceuticals Latest Developments
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Information
11.10.2 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Offered
11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Gilead Sciences Inc. Main Business Overview
11.10.5 Gilead Sciences Inc. Latest Developments
11.11 Genentech Inc.
11.11.1 Genentech Inc. Company Information
11.11.2 Genentech Inc. Crohn’s Disease Therapeutics Product Offered
11.11.3 Genentech Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Genentech Inc. Main Business Overview
11.11.5 Genentech Inc. Latest Developments
11.12 UCB India Private Limited.
11.12.1 UCB India Private Limited. Company Information
11.12.2 UCB India Private Limited. Crohn’s Disease Therapeutics Product Offered
11.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 UCB India Private Limited. Main Business Overview
11.12.5 UCB India Private Limited. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Crohn’s Disease Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Non-Surgical
Table 3. Major Players of Surgical
Table 4. Crohn’s Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 7. Crohn’s Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 10. Global Crohn’s Disease Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Crohn’s Disease Therapeutics Revenue Market Share by Player (2019-2024)
Table 12. Crohn’s Disease Therapeutics Key Players Head office and Products Offered
Table 13. Crohn’s Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Crohn’s Disease Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Crohn’s Disease Therapeutics Market Size Market Share by Regions (2019-2024)
Table 18. Global Crohn’s Disease Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Crohn’s Disease Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Crohn’s Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Crohn’s Disease Therapeutics Market Size Market Share by Country (2019-2024)
Table 22. Americas Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 24. Americas Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 26. APAC Crohn’s Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Crohn’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Table 28. APAC Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. APAC Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. Europe Crohn’s Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Crohn’s Disease Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. Europe Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Crohn’s Disease Therapeutics
Table 45. Key Market Challenges & Risks of Crohn’s Disease Therapeutics
Table 46. Key Industry Trends of Crohn’s Disease Therapeutics
Table 47. Global Crohn’s Disease Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Crohn’s Disease Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Crohn’s Disease Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Johnson and Johnson Services Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 52. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Offered
Table 53. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Johnson and Johnson Services Inc. Main Business
Table 55. Johnson and Johnson Services Inc. Latest Developments
Table 56. Pfizer Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 57. Pfizer Inc. Crohn’s Disease Therapeutics Product Offered
Table 58. Pfizer Inc. Main Business
Table 59. Pfizer Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pfizer Inc. Latest Developments
Table 61. Allergan Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 62. Allergan Crohn’s Disease Therapeutics Product Offered
Table 63. Allergan Main Business
Table 64. Allergan Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Allergan Latest Developments
Table 66. AbbVie Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 67. AbbVie Inc. Crohn’s Disease Therapeutics Product Offered
Table 68. AbbVie Inc. Main Business
Table 69. AbbVie Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. AbbVie Inc. Latest Developments
Table 71. Takeda Pharmaceutical Company Limited Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 72. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Offered
Table 73. Takeda Pharmaceutical Company Limited Main Business
Table 74. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Takeda Pharmaceutical Company Limited Latest Developments
Table 76. Celgene Corporation Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 77. Celgene Corporation Crohn’s Disease Therapeutics Product Offered
Table 78. Celgene Corporation Main Business
Table 79. Celgene Corporation Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Celgene Corporation Latest Developments
Table 81. Perrigo Company PLC Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 82. Perrigo Company PLC Crohn’s Disease Therapeutics Product Offered
Table 83. Perrigo Company PLC Main Business
Table 84. Perrigo Company PLC Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Perrigo Company PLC Latest Developments
Table 86. Ferring B.V. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 87. Ferring B.V. Crohn’s Disease Therapeutics Product Offered
Table 88. Ferring B.V. Main Business
Table 89. Ferring B.V. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Ferring B.V. Latest Developments
Table 91. Salix Pharmaceuticals Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 92. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Offered
Table 93. Salix Pharmaceuticals Main Business
Table 94. Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Salix Pharmaceuticals Latest Developments
Table 96. Gilead Sciences Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 97. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Offered
Table 98. Gilead Sciences Inc. Main Business
Table 99. Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Gilead Sciences Inc. Latest Developments
Table 101. Genentech Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 102. Genentech Inc. Crohn’s Disease Therapeutics Product Offered
Table 103. Genentech Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Genentech Inc. Main Business
Table 105. Genentech Inc. Latest Developments
Table 106. UCB India Private Limited. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 107. UCB India Private Limited. Crohn’s Disease Therapeutics Product Offered
Table 108. UCB India Private Limited. Main Business
Table 109. UCB India Private Limited. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. UCB India Private Limited. Latest Developments
Table 1. Crohn’s Disease Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Non-Surgical
Table 3. Major Players of Surgical
Table 4. Crohn’s Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 7. Crohn’s Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 10. Global Crohn’s Disease Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Crohn’s Disease Therapeutics Revenue Market Share by Player (2019-2024)
Table 12. Crohn’s Disease Therapeutics Key Players Head office and Products Offered
Table 13. Crohn’s Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Crohn’s Disease Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Crohn’s Disease Therapeutics Market Size Market Share by Regions (2019-2024)
Table 18. Global Crohn’s Disease Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Crohn’s Disease Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Crohn’s Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Crohn’s Disease Therapeutics Market Size Market Share by Country (2019-2024)
Table 22. Americas Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 24. Americas Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 26. APAC Crohn’s Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Crohn’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Table 28. APAC Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. APAC Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. Europe Crohn’s Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Crohn’s Disease Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. Europe Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Crohn’s Disease Therapeutics
Table 45. Key Market Challenges & Risks of Crohn’s Disease Therapeutics
Table 46. Key Industry Trends of Crohn’s Disease Therapeutics
Table 47. Global Crohn’s Disease Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Crohn’s Disease Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Crohn’s Disease Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Johnson and Johnson Services Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 52. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Offered
Table 53. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Johnson and Johnson Services Inc. Main Business
Table 55. Johnson and Johnson Services Inc. Latest Developments
Table 56. Pfizer Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 57. Pfizer Inc. Crohn’s Disease Therapeutics Product Offered
Table 58. Pfizer Inc. Main Business
Table 59. Pfizer Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pfizer Inc. Latest Developments
Table 61. Allergan Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 62. Allergan Crohn’s Disease Therapeutics Product Offered
Table 63. Allergan Main Business
Table 64. Allergan Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Allergan Latest Developments
Table 66. AbbVie Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 67. AbbVie Inc. Crohn’s Disease Therapeutics Product Offered
Table 68. AbbVie Inc. Main Business
Table 69. AbbVie Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. AbbVie Inc. Latest Developments
Table 71. Takeda Pharmaceutical Company Limited Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 72. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Offered
Table 73. Takeda Pharmaceutical Company Limited Main Business
Table 74. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Takeda Pharmaceutical Company Limited Latest Developments
Table 76. Celgene Corporation Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 77. Celgene Corporation Crohn’s Disease Therapeutics Product Offered
Table 78. Celgene Corporation Main Business
Table 79. Celgene Corporation Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Celgene Corporation Latest Developments
Table 81. Perrigo Company PLC Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 82. Perrigo Company PLC Crohn’s Disease Therapeutics Product Offered
Table 83. Perrigo Company PLC Main Business
Table 84. Perrigo Company PLC Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Perrigo Company PLC Latest Developments
Table 86. Ferring B.V. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 87. Ferring B.V. Crohn’s Disease Therapeutics Product Offered
Table 88. Ferring B.V. Main Business
Table 89. Ferring B.V. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Ferring B.V. Latest Developments
Table 91. Salix Pharmaceuticals Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 92. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Offered
Table 93. Salix Pharmaceuticals Main Business
Table 94. Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Salix Pharmaceuticals Latest Developments
Table 96. Gilead Sciences Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 97. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Offered
Table 98. Gilead Sciences Inc. Main Business
Table 99. Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Gilead Sciences Inc. Latest Developments
Table 101. Genentech Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 102. Genentech Inc. Crohn’s Disease Therapeutics Product Offered
Table 103. Genentech Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Genentech Inc. Main Business
Table 105. Genentech Inc. Latest Developments
Table 106. UCB India Private Limited. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors
Table 107. UCB India Private Limited. Crohn’s Disease Therapeutics Product Offered
Table 108. UCB India Private Limited. Main Business
Table 109. UCB India Private Limited. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. UCB India Private Limited. Latest Developments
LIST OF FIGURES
Figure 1. Crohn’s Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Crohn’s Disease Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Crohn’s Disease Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Crohn’s Disease Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Crohn’s Disease Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Crohn’s Disease Therapeutics Market Size Market Share by Type in 2023
Figure 10. Crohn’s Disease Therapeutics in Hospitals
Figure 11. Global Crohn’s Disease Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Crohn’s Disease Therapeutics in Ambulatory Surgical Centers
Figure 13. Global Crohn’s Disease Therapeutics Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 14. Global Crohn’s Disease Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Crohn’s Disease Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Crohn’s Disease Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Crohn’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Crohn’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Crohn’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Crohn’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Crohn’s Disease Therapeutics Value Market Share by Country in 2023
Figure 22. United States Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Crohn’s Disease Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Crohn’s Disease Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Crohn’s Disease Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Crohn’s Disease Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Crohn’s Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Crohn’s Disease Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Crohn’s Disease Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Crohn’s Disease Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Crohn’s Disease Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Crohn’s Disease Therapeutics Market Size Market Share by Type in 2023
Figure 10. Crohn’s Disease Therapeutics in Hospitals
Figure 11. Global Crohn’s Disease Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Crohn’s Disease Therapeutics in Ambulatory Surgical Centers
Figure 13. Global Crohn’s Disease Therapeutics Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 14. Global Crohn’s Disease Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Crohn’s Disease Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Crohn’s Disease Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Crohn’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Crohn’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Crohn’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Crohn’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Crohn’s Disease Therapeutics Value Market Share by Country in 2023
Figure 22. United States Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Crohn’s Disease Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Crohn’s Disease Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Crohn’s Disease Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Crohn’s Disease Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Crohn’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Crohn’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Application (2025-2030)
